Is a Drug-Eluting Stent the Default Treatment Strategy for Drug-Eluting Stent Restenosis?

Affiliations

¹ Department of Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy; Department of Interventional Cardiology, EMO-GVM Centro Cuore Columbus, Milan, Italy. Electronic address: info@emocolumbus.it.
² Department of Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy; Department of Interventional Cardiology, EMO-GVM Centro Cuore Columbus, Milan, Italy; Department of Cardiology, Imperial College, London, United Kingdom.

Free article

Editorial

Antonio Colombo et al. J Am Coll Cardiol. 2015.

Free article

. 2015 Jul 7;66(1):34-6.

doi: 10.1016/j.jacc.2015.04.055.

¹ Department of Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy; Department of Interventional Cardiology, EMO-GVM Centro Cuore Columbus, Milan, Italy. Electronic address: info@emocolumbus.it.
² Department of Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy; Department of Interventional Cardiology, EMO-GVM Centro Cuore Columbus, Milan, Italy; Department of Cardiology, Imperial College, London, United Kingdom.

No abstract available

Keywords: drug-eluting balloon; drug-eluting stent(s); in-stent restenosis; percutaneous coronary intervention.

Comment on

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.
Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, García del Blanco B, García-Touchard A, López-Minguéz JR, Benedicto A, Masotti M, Zueco J, Iñiguez A, Velázquez M, Moreno R, Mainar V, Domínguez A, Pomar F, Melgares R, Rivero F, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C; RIBS IV Study Investigators (under auspices of Interventional Cardiology Working Group of Spanish Society of Cardiology). Alfonso F, et al. J Am Coll Cardiol. 2015 Jul 7;66(1):23-33. doi: 10.1016/j.jacc.2015.04.063. J Am Coll Cardiol. 2015. PMID: 26139054 Clinical Trial.